-
1
-
-
10744233940
-
Pulmonary hypertension as a risk factor for death in patients with sickle cell disease
-
Gladwin MT, Sachdev V, Jison ML, Shizukuda Y, Plehn JF, Minter K et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med 2004; 350: 886-895.
-
(2004)
N Engl J Med
, vol.350
, pp. 886-895
-
-
Gladwin, M.T.1
Sachdev, V.2
Jison, M.L.3
Shizukuda, Y.4
Plehn, J.F.5
Minter, K.6
-
2
-
-
33644775612
-
Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease
-
Kato GJ, McGowan V, Machado RF, Little JA, Jt Taylor, Morris CR et al. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood 2006; 107: 2279-2285.
-
(2006)
Blood
, vol.107
, pp. 2279-2285
-
-
Kato, G.J.1
McGowan, V.2
Machado, R.F.3
Little, J.A.4
Taylor, J.T.5
Morris, C.R.6
-
3
-
-
0028291736
-
Mortality in sickle cell disease. Life expectancy and risk factors for early death
-
Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994; 330: 1639-1644.
-
(1994)
N Engl J Med
, vol.330
, pp. 1639-1644
-
-
Platt, O.S.1
Brambilla, D.J.2
Rosse, W.F.3
Milner, P.F.4
Castro, O.5
Steinberg, M.H.6
-
5
-
-
34948830175
-
Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease
-
Bernaudin F, Socie G, Kuentz M, Chevret S, Duval M, Bertrand Y et al. Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease. Blood 2007; 110: 2749-2756.
-
(2007)
Blood
, vol.110
, pp. 2749-2756
-
-
Bernaudin, F.1
Socie, G.2
Kuentz, M.3
Chevret, S.4
Duval, M.5
Bertrand, Y.6
-
6
-
-
0021593369
-
Bone-marrow transplantation in a patient with sickle-cell anemia
-
Johnson FL, Look AT, Gockerman J, Ruggiero MR, Dalla-Pozza L, Billings 3rd FT. Bone-marrow transplantation in a patient with sickle-cell anemia. N Engl J Med 1984; 311: 780-783.
-
(1984)
N Engl J Med
, vol.311
, pp. 780-783
-
-
Johnson, F.L.1
Look, A.T.2
Gockerman, J.3
Ruggiero, M.R.4
Dalla-Pozza, L.5
Billings III, F.T.6
-
7
-
-
0031870487
-
Haematopoietic stem cell transplantation for sickle cell anaemia: The first 50 patients transplanted in Belgium
-
Vermylen C, Cornu G, Ferster A, Brichard B, Ninane J, Ferrant et al. Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium. Bone Marrow Transplant 1998; 22: 1-6.
-
(1998)
Bone Marrow Transplant
, vol.22
, pp. 1-6
-
-
Vermylen, C.1
Cornu, G.2
Ferster, A.3
Brichard, B.4
Ninane, J.5
Ferrant6
-
8
-
-
9344231922
-
Bone marrow transplantation for sickle cell disease
-
Walters MC, Patience M, Leisenring W, Eckman JR, Scott JP, Mentzer WC et al. Bone marrow transplantation for sickle cell disease. N Engl J Med 1996; 335: 369-376.
-
(1996)
N Engl J Med
, vol.335
, pp. 369-376
-
-
Walters, M.C.1
Patience, M.2
Leisenring, W.3
Eckman, J.R.4
Scott, J.P.5
Mentzer, W.C.6
-
9
-
-
84886897873
-
Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling
-
Locatelli F, Kabbara N, Ruggeri A, Ghavamzadeh A, Roberts I, Li CK et al. Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling. Blood 2013; 122: 1072-1078.
-
(2013)
Blood
, vol.122
, pp. 1072-1078
-
-
Locatelli, F.1
Kabbara, N.2
Ruggeri, A.3
Ghavamzadeh, A.4
Roberts, I.5
Li, C.K.6
-
10
-
-
38849161460
-
Hematopoietic cell transplantation for thalassemia and sickle cell disease: Past, present and future
-
Bhatia M, Walters MC. Hematopoietic cell transplantation for thalassemia and sickle cell disease: past, present and future. Bone Marrow Transplant 2008; 41: 109-117.
-
(2008)
Bone Marrow Transplant
, vol.41
, pp. 109-117
-
-
Bhatia, M.1
Walters, M.C.2
-
11
-
-
75149170038
-
Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell disease
-
Walters MC, Hardy K, Edwards S, Adamkiewicz T, Barkovich J, Bernaudin F et al. Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell disease. Biol Blood Marrow Transplant 2010; 16: 263-272.
-
(2010)
Biol Blood Marrow Transplant
, vol.16
, pp. 263-272
-
-
Walters, M.C.1
Hardy, K.2
Edwards, S.3
Adamkiewicz, T.4
Barkovich, J.5
Bernaudin, F.6
-
12
-
-
0030133622
-
Barriers to bone marrow transplantation for sickle cell anemia
-
Walters MC, Patience M, Leisenring W, Eckman JR, Buchanan GR, Rogers ZR et al. Barriers to bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant 1996; 2: 100-104.
-
(1996)
Biol Blood Marrow Transplant
, vol.2
, pp. 100-104
-
-
Walters, M.C.1
Patience, M.2
Leisenring, W.3
Eckman, J.R.4
Buchanan, G.R.5
Rogers, Z.R.6
-
13
-
-
19944392296
-
Reduced-intensity allogeneic stem cell transplantation in adults and children with malignant and nonmalignant diseases: End of the beginning and future challenges
-
Satwani P, Harrison L, Morris E, Del Toro G, Cairo MS. Reduced-intensity allogeneic stem cell transplantation in adults and children with malignant and nonmalignant diseases: end of the beginning and future challenges. Biol Blood Marrow Transplant 2005; 11: 403-422.
-
(2005)
Biol Blood Marrow Transplant
, vol.11
, pp. 403-422
-
-
Satwani, P.1
Harrison, L.2
Morris, E.3
Del Toro, G.4
Cairo, M.S.5
-
14
-
-
36849036789
-
Reduced intensity and non-myeloablative allogeneic stem cell transplantation in children and adolescents with malignant and non-malignant diseases
-
Satwani P, Morris E, BradLey MB, Bhatia M, van de Ven C, Cairo MS. Reduced intensity and non-myeloablative allogeneic stem cell transplantation in children and adolescents with malignant and non-malignant diseases. Pediatr Blood Cancer 2008; 50: 1-8.
-
(2008)
Pediatr Blood Cancer
, vol.50
, pp. 1-8
-
-
Satwani, P.1
Morris, E.2
Bradley, M.B.3
Bhatia, M.4
Van De Ven, C.5
Cairo, M.S.6
-
15
-
-
79958089426
-
A pilot study of reduced toxicity conditioning with BU, fludarabine and alemtuzumab before the allogeneic hematopoietic SCT in children and adolescents
-
Styczynski J, Tallamy B, Waxman I, van de Ven C, Milone MC, Shaw LM et al. A pilot study of reduced toxicity conditioning with BU, fludarabine and alemtuzumab before the allogeneic hematopoietic SCT in children and adolescents. Bone Marrow Transplant 2011; 46: 790-799.
-
(2011)
Bone Marrow Transplant
, vol.46
, pp. 790-799
-
-
Styczynski, J.1
Tallamy, B.2
Waxman, I.3
Van De Ven, C.4
Milone, M.C.5
Shaw, L.M.6
-
16
-
-
71849118976
-
Allogeneic hematopoietic stem-cell transplantation for sickle cell disease
-
Hsieh MM, Kang EM, Fitzhugh CD, Link MB, Bolan CD, Kurlander R et al. Allogeneic hematopoietic stem-cell transplantation for sickle cell disease. N Engl J Med 2009; 361: 2309-2317.
-
(2009)
N Engl J Med
, vol.361
, pp. 2309-2317
-
-
Hsieh, M.M.1
Kang, E.M.2
Fitzhugh, C.D.3
Link, M.B.4
Bolan, C.D.5
Kurlander, R.6
-
17
-
-
80053560138
-
A comparison of immune reconstitution and graft-versus-host disease following myeloablative conditioning versus reduced toxicity conditioning and umbilical cord blood transplantation in paediatric recipients
-
Geyer MB, Jacobson JS, Freedman J, George D, Moore V, van de Ven C et al. A comparison of immune reconstitution and graft-versus-host disease following myeloablative conditioning versus reduced toxicity conditioning and umbilical cord blood transplantation in paediatric recipients. Br J Haematol 2011; 155: 218-234.
-
(2011)
Br J Haematol
, vol.155
, pp. 218-234
-
-
Geyer, M.B.1
Jacobson, J.S.2
Freedman, J.3
George, D.4
Moore, V.5
Van De Ven, C.6
-
18
-
-
84872149353
-
The pharmacokinetics and safety of twice daily I.V
-
Le Gall JB, Milone MC, Waxman IM, Shaw LM, Harrison L, Duffy D et al. The pharmacokinetics and safety of twice daily i.v. BU during conditioning in pediatric allo-SCT recipients. Bone Marrow Transplant 2013; 48: 19-25.
-
(2013)
BU during Conditioning in Pediatric Allo-SCT Recipients. Bone Marrow Transplant
, vol.48
, pp. 19-25
-
-
Le Gall, J.B.1
Milone, M.C.2
Waxman, I.M.3
Shaw, L.M.4
Harrison, L.5
Duffy, D.6
-
19
-
-
11144354112
-
A pilot study of tacrolimus and mycophenolate mofetil graft-versus-host disease prophylaxis in childhood and adolescent allogeneic stem cell transplant recipients
-
Osunkwo I, Bessmertny O, Harrison L, Cheung YK, Van de Ven C, del Toro G et al. A pilot study of tacrolimus and mycophenolate mofetil graft-versus-host disease prophylaxis in childhood and adolescent allogeneic stem cell transplant recipients. Biol Blood Marrow Transplant 2004; 10: 246-258.
-
(2004)
Biol Blood Marrow Transplant
, vol.10
, pp. 246-258
-
-
Osunkwo, I.1
Bessmertny, O.2
Harrison, L.3
Cheung, Y.K.4
Van De Ven, C.5
Del Toro, G.6
-
20
-
-
75749085170
-
An age-dependent pharmacokinetic study of intravenous and oral mycophenolate mofetil in combination with tacrolimus for GVHD prophylaxis in pediatric allogeneic stem cell transplantation recipients
-
Bhatia M, Militano O, Jin Z, Figurski M, Shaw L, Moore V et al. An age-dependent pharmacokinetic study of intravenous and oral mycophenolate mofetil in combination with tacrolimus for GVHD prophylaxis in pediatric allogeneic stem cell transplantation recipients. Biol Blood Marrow Transplant 2010; 16: 333-343.
-
(2010)
Biol Blood Marrow Transplant
, vol.16
, pp. 333-343
-
-
Bhatia, M.1
Militano, O.2
Jin, Z.3
Figurski, M.4
Shaw, L.5
Moore, V.6
-
21
-
-
0016187133
-
Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors
-
Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295-304.
-
(1974)
Transplantation
, vol.18
, pp. 295-304
-
-
Glucksberg, H.1
Storb, R.2
Fefer, A.3
Buckner, C.D.4
Neiman, P.E.5
Clift, R.A.6
-
22
-
-
65549157537
-
Sequential administration of sargramostim and filgrastim in pediatric allogeneic stem cell transplantation recipients undergoing myeloablative conditioning
-
Waxman IM, Militano O, Baldinger L, Roman E, Qualter E, Morris E et al. Sequential administration of sargramostim and filgrastim in pediatric allogeneic stem cell transplantation recipients undergoing myeloablative conditioning. Pediatr Transplant 2009; 13: 464-474.
-
(2009)
Pediatr Transplant
, vol.13
, pp. 464-474
-
-
Waxman, I.M.1
Militano, O.2
Baldinger, L.3
Roman, E.4
Qualter, E.5
Morris, E.6
-
23
-
-
37549006408
-
Liposomal amphotericin B prophylaxis of invasive mold infections in children post allogeneic stem cell transplantation
-
Roman E, Osunkwo I, Militano O, Cooney E, van de Ven C, Cairo MS. Liposomal amphotericin B prophylaxis of invasive mold infections in children post allogeneic stem cell transplantation. Pediatr Blood Cancer 2008; 50: 325-330.
-
(2008)
Pediatr Blood Cancer
, vol.50
, pp. 325-330
-
-
Roman, E.1
Osunkwo, I.2
Militano, O.3
Cooney, E.4
Van De Ven, C.5
Cairo, M.S.6
-
24
-
-
34547775136
-
A pilot phase II study of alternate day ganciclovir and foscarnet in preventing cytomegalovirus (CMV) infections in at-risk pediatric and adolescent allogeneic stem cell transplant recipients
-
Shereck EB, Cooney E, van de Ven C, Della-Lotta P, Cairo MS. A pilot phase II study of alternate day ganciclovir and foscarnet in preventing cytomegalovirus (CMV) infections in at-risk pediatric and adolescent allogeneic stem cell transplant recipients. Pediatr Blood Cancer 2007; 49: 306-312.
-
(2007)
Pediatr Blood Cancer
, vol.49
, pp. 306-312
-
-
Shereck, E.B.1
Cooney, E.2
Van De Ven, C.3
Della-Lotta, P.4
Cairo, M.S.5
-
25
-
-
63949085142
-
Feasibility study of preemptive withdrawal of immunosuppression based on chimerism testing in children undergoing myeloablative allogeneic transplantation for hematologic malignancies
-
Horn B, Soni S, Khan S, Petrovic A, Breslin N, Cowan M et al. Feasibility study of preemptive withdrawal of immunosuppression based on chimerism testing in children undergoing myeloablative allogeneic transplantation for hematologic malignancies. Bone Marrow Transplant 2009; 43: 469-476.
-
(2009)
Bone Marrow Transplant
, vol.43
, pp. 469-476
-
-
Horn, B.1
Soni, S.2
Khan, S.3
Petrovic, A.4
Breslin, N.5
Cowan, M.6
-
26
-
-
70350572382
-
Incidence of Viral and fungal infections following busulfan-based reducedintensity versus myeloablative conditioning in pediatric allogeneic stem cell transplantation recipients
-
Satwani P, Baldinger L, Freedman J, Jacobson JS, Guerra J, van de Ven C et al. Incidence of Viral and fungal infections following busulfan-based reducedintensity versus myeloablative conditioning in pediatric allogeneic stem cell transplantation recipients. Biol Blood Marrow Transplant 2009; 15: 1587-1595.
-
(2009)
Biol Blood Marrow Transplant
, vol.15
, pp. 1587-1595
-
-
Satwani, P.1
Baldinger, L.2
Freedman, J.3
Jacobson, J.S.4
Guerra, J.5
Van De Ven, C.6
-
27
-
-
84862908566
-
Risk factors for acute GVHDand survival after hematopoietic cell transplantation
-
Jagasia M, Arora M, Flowers ME, Chao NJ, McCarthy PL, Cutler CS et al. Risk factors for acute GVHDand survival after hematopoietic cell transplantation. Blood 2012; 119: 296-307.
-
(2012)
Blood
, vol.119
, pp. 296-307
-
-
Jagasia, M.1
Arora, M.2
Flowers, M.E.3
Chao, N.J.4
McCarthy, P.L.5
Cutler, C.S.6
-
28
-
-
84873423706
-
Concise review: Acute graft-versus-host disease: Immunobiology, prevention, and treatment
-
Sung AD, Chao NJ. Concise review: acute graft-versus-host disease: immunobiology, prevention, and treatment. Stem Cells Transl Med 2013; 2: 25-32.
-
(2013)
Stem Cells Transl Med
, vol.2
, pp. 25-32
-
-
Sung, A.D.1
Chao, N.J.2
-
29
-
-
53749086728
-
Stable long-term donor engraftment following reduced-intensity hematopoietic cell transplantation for sickle cell disease
-
Krishnamurti L, Kharbanda S, Biernacki MA, Zhang W, Baker KS, Wagner JE et al. Stable long-term donor engraftment following reduced-intensity hematopoietic cell transplantation for sickle cell disease. Biol Blood Marrow Transplant 2008; 14: 1270-1278.
-
(2008)
Biol Blood Marrow Transplant
, vol.14
, pp. 1270-1278
-
-
Krishnamurti, L.1
Kharbanda, S.2
Biernacki, M.A.3
Zhang, W.4
Baker, K.S.5
Wagner, J.E.6
-
30
-
-
34247858963
-
Matched-related donor transplantation for sickle cell disease: Report from the Center for International Blood and Transplant Research
-
Panepinto JA, Walters MC, Carreras J, Marsh J, Bredeson CN, Gale RP et al. Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research. Br J Haematol 2007; 137: 479-485.
-
(2007)
Br J Haematol
, vol.137
, pp. 479-485
-
-
Panepinto, J.A.1
Walters, M.C.2
Carreras, J.3
Marsh, J.4
Bredeson, C.N.5
Gale, R.P.6
-
31
-
-
84875514036
-
Transplantationrelated mortality, graft failure, and survival after reduced-toxicity conditioningand allogeneic hematopoietic stem cell transplantation in 100 consecutive pediatric recipients
-
Satwani P, Jin Z, Duffy D, Morris E, Bhatia M, Garvin JH et al. Transplantationrelated mortality, graft failure, and survival after reduced-toxicity conditioningand allogeneic hematopoietic stem cell transplantation in 100 consecutive pediatric recipients. Biol Blood Marrow Transplant 2013; 19: 552-561.
-
(2013)
Biol Blood Marrow Transplant
, vol.19
, pp. 552-561
-
-
Satwani, P.1
Jin, Z.2
Duffy, D.3
Morris, E.4
Bhatia, M.5
Garvin, J.H.6
-
32
-
-
0035544031
-
Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia
-
Walters MC, Patience M, Leisenring W, Rogers ZR, Aquino VM, Buchanan GR et al. Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant 2001; 7: 665-673.
-
(2001)
Biol Blood Marrow Transplant
, vol.7
, pp. 665-673
-
-
Walters, M.C.1
Patience, M.2
Leisenring, W.3
Rogers, Z.R.4
Aquino, V.M.5
Buchanan, G.R.6
-
33
-
-
0036220398
-
Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke
-
Scothorn DJ, Price C, Schwartz D, Terrill C, Buchanan GR, Shurney W et al. Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke. J Pediatr 2002; 140: 348-354.
-
(2002)
J Pediatr
, vol.140
, pp. 348-354
-
-
Scothorn, D.J.1
Price, C.2
Schwartz, D.3
Terrill, C.4
Buchanan, G.R.5
Shurney, W.6
-
34
-
-
77649200764
-
High incidence of severe cyclosporine neurotoxicity in children affected by haemoglobinopaties undergoing myeloablative haematopoietic stem cell transplantation: Early diagnosis and prompt intervention ameliorates neurological outcome
-
Noe A, Cappelli B, Biffi A, Chiesa R, Frugnoli I, Biral E et al. High incidence of severe cyclosporine neurotoxicity in children affected by haemoglobinopaties undergoing myeloablative haematopoietic stem cell transplantation: early diagnosis and prompt intervention ameliorates neurological outcome. Ital J Pediatr 2010; 36: 14.
-
(2010)
Ital J Pediatr
, vol.36
, pp. 14
-
-
Noe, A.1
Cappelli, B.2
Biffi, A.3
Chiesa, R.4
Frugnoli, I.5
Biral, E.6
-
35
-
-
0037669432
-
Tacrolimusassociated posterior reversible encephalopathy syndrome after allogeneic haematopoietic stem cell transplantation
-
Wong R, Beguelin GZ, de Lima M, Giralt SA, Hosing C, Ippoliti C et al. Tacrolimusassociated posterior reversible encephalopathy syndrome after allogeneic haematopoietic stem cell transplantation. Br J Haematol 2003; 122: 128-134.
-
(2003)
Br J Haematol
, vol.122
, pp. 128-134
-
-
Wong, R.1
Beguelin, G.Z.2
De Lima, M.3
Giralt, S.A.4
Hosing, C.5
Ippoliti, C.6
-
36
-
-
84870804411
-
Allogeneic cellular and autologous stem cell therapy for sickle cell disease: 'Whom, When And How'
-
Freed J, Talano J, Small T, Ricci A, Cairo MS. Allogeneic cellular and autologous stem cell therapy for sickle cell disease: 'whom, when and how'. Bone Marrow Transplant 2012; 47: 1489-1498.
-
(2012)
Bone Marrow Transplant
, vol.47
, pp. 1489-1498
-
-
Freed, J.1
Talano, J.2
Small, T.3
Ricci, A.4
Cairo, M.S.5
-
37
-
-
84880698186
-
Sickle cell disease: Time for a closer look at treatment options?
-
Sheth S, Licursi M, Bhatia M. Sickle cell disease: time for a closer look at treatment options? Br J Haematol 2013; 162: 455-464.
-
(2013)
Br J Haematol
, vol.162
, pp. 455-464
-
-
Sheth, S.1
Licursi, M.2
Bhatia, M.3
|